Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Biomarkers as a Non-invasive Approach for Early Diagnosis of Lung Cancer

NCT04558255 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT04558255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04558255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Biomarkers as a Non-invasive Approach for Early Diagnosis of Lung Cancer
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2020
Completion date
December 1, 2021
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer